Novartis AG-Strategy, SWOT and Corporate Finance Report
Novartis AG-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Novartis AG (Novartis or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is involved in the research, development, manufacture and marketing of medicines, eye care products and generic pharmaceuticals. In addition, it offers these products to treat cancer, cardiovascular, dermatological, neurological, ophthalmic, respiratory and infectious diseases, and immune disorders.It also conducts various research and development activities through its Novartis Institutes for BioMedical Research (NIBR). Novartis is headquartered in Basel, Switzerland.
- Detailed information on Novartis AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
- An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
- Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novartis AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Novartis AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novartis AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novartis AG's business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 5
Novartis AG: Company Overview 9
Novartis AG: Overview and Key Facts 9
Novartis AG: Overview 9
Novartis AG: Key Facts 9
Novartis AG: Key Employees 11
Novartis AG: Key Employee Biographies 13
Novartis AG: Major Products and Services 22
Novartis AG: Company History 24
Novartis AG: Management Statement 38
Novartis AG: Locations and Subsidiaries 40
Novartis AG: Key Competitors 41
Novartis AG: Company Analysis 42
Novartis AG: Business Description 42
Novartis AG: SWOT Analysis 44
Novartis AG: SWOT Overview 44
Novartis AG: Strengths 44
Novartis AG: Weaknesses 45
Novartis AG: Opportunities 46
Novartis AG: Threats 47
Novartis AG: Corporate Financial Deals Activity 49
Novartis AG: Financial Deals Overview 49
Novartis AG: Targets and Partners 51
Novartis AG: Top Deals 2014-2018YTD 56
Novartis AG: Advisors 57
Novartis AG: Top Legal Advisors 57
Novartis AG: Top Financial Advisors 57
Novartis AG: Mergers and Acquisitions 58
Novartis AG: Corporate Venturing 59
Novartis AG: Capital Raising 60
Novartis AG: Partnership 61
Novartis AG: Divestments 62
Novartis AG: Recent Developments 63
Novartis AG: News and Events Summary 63
Novartis AG: Contracts 67
Novartis AG: Regulatory and Legal Events 69
Novartis AG: Research & Development 69
Novartis AG: Strategy and Operations 70
Contact Us 72
About MarketLine 73
List of Figures
Figure 1: Novartis AG: Deal Activity by Deal Type-Volume (TTM )
Figure 2: Novartis AG: Deal Activity by Deal Type-Volume (2014-YTD 2018)
Figure 3: Novartis AG: M&A Average Deal Size-Value (USD m)
Figure 4: Novartis AG: M&A
Single User License:
Corporate User License:
select a license
NEWSLETTER BY CATEGORY
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"
An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ... "General Manager SBU Manufacture, PT. KIMIA FARMA, TBK"